What changed
A protein's shape helps determine what it does, but experimental structure work can take months or years. AlphaFold predicts a likely three-dimensional structure from an amino-acid sequence, then publishes confidence scores that show which parts deserve more or less trust.
The AlphaFold Protein Structure Database expanded that capability to more than 214 million sequences. Instead of beginning with a blank page, researchers studying a pathogen, crop, rare disease, or basic cell process can often begin with a testable structural hypothesis.
What this could change for you
There is no instant medicine hiding inside the number 214 million. The everyday change is farther upstream: scientists can eliminate dead ends earlier, design experiments with more context, and ask better questions about proteins that previously had no structural information.
That can accelerate drug discovery, enzyme design, and disease research, especially for small teams that could never solve thousands of structures themselves. Because the database is open, access is not limited to one company.
What it does not prove
These are predictions, not 214 million experimentally proven structures. Flexible regions, molecular partners, chemical modifications, and alternate conformations can all change what a protein looks like in a living cell.
A plausible structure does not reveal whether a drug is safe, whether it works in a person, or how a disease behaves. Researchers must use confidence scores and verify the important claims experimentally.
The bottom line
AlphaFold did not solve biology, but it removed an enormous structural-information bottleneck. The public database turns years of possible starting work into something a scientist can inspect in seconds—then the real experiment begins.
Primary research
AlphaFold Protein Structure Database in 2024: providing structure coverage for over 214 million protein sequences
Nucleic Acids Research · 2024 · DOI 10.1093/nar/gkad1011
